Search Results - "Steidler, L"

Refine Results
  1. 1

    Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis by Vandenbroucke, K, de Haard, H, Beirnaert, E, Dreier, T, Lauwereys, M, Huyck, L, Van Huysse, J, Demetter, P, Steidler, L, Remaut, E, Cuvelier, C, Rottiers, P

    Published in Mucosal immunology (2010)
    “…Inflammatory bowel disease (IBD) is a chronic inflammatory gastrointestinal disorder. Systemic treatment of IBD patients with anti-tumor necrosis factor…”
    Get full text
    Journal Article
  2. 2

    Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10 by Steidler, Lothar, Hans, Wolfgang, Schotte, Lieven, Neirynck, Sabine, Obermeier, Florian, Falk, Werner, Fiers, Walter, Remaut, Erik

    “…The cytokine interleukin-10 (IL-10) has shown promise in clinical trials for treatment of inflammatory bowel disease (IBD). Using two mouse models, we show…”
    Get full text
    Journal Article
  3. 3

    Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists by Mahmoud, Amer Z, George, Tracy I, Czuchlewski, David R, Zhang, Qian-Yun, Wilson, Carla S, Sever, Cordelia E, Bakhirev, Alexei G, Zhang, Dahua, Steidler, Nichole L, Reichard, Kaaren K, Kang, Huining, Foucar, Kathryn, Vasef, Mohammad A

    Published in Modern pathology (01-04-2015)
    “…Recent studies have shown that immunohistochemical evaluation of MYC protein expression in diffuse large B-cell lymphoma is a useful prognostic tool with high…”
    Get full text
    Journal Article
  4. 4

    Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression in Lactococcus lactis by Robert, S, Van Huynegem, K, Gysemans, C, Mathieu, C, Rottiers, P, Steidler, L

    Published in Beneficial microbes (01-01-2015)
    “…Type 1 diabetes (T1D) is a chronic autoimmune disease characterised by excessive immune reactions against auto-antigens of pancreatic β-cells. Restoring…”
    Get more information
    Journal Article
  5. 5

    Secretion of biologically active murine interleukin-10 by Lactococcus lactis by Schotte, L., Steidler, L., Vandekerckhove, J., Remaut, E.

    Published in Enzyme and microbial technology (01-12-2000)
    “…We investigated the ability of Lactococcus lactis to secrete biologically active, murine interleukin-10 (mIL-10). mIL-10 was synthesized as a fusion protein,…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn’s disease by Laukens, D, Peeters, H, Marichal, D, Vander Cruyssen, B, Mielants, H, Elewaut, D, Demetter, P, Cuvelier, C, Van Den Berghe, M, Rottiers, P, Veys, E M, Remaut, E, Steidler, L, De Keyser, F, De Vos, M

    Published in Annals of the rheumatic diseases (01-06-2005)
    “…Background: The association between spondyloarthropathy and Crohn’s disease is well known. A risk for evolution to Crohn’s disease has already been shown in…”
    Get full text
    Journal Article
  7. 7

    Altered gut transcriptome in spondyloarthropathy by Laukens, D, Peeters, H, Cruyssen, B V, Boonefaes, T, Elewaut, D, De Keyser, F, Mielants, H, Cuvelier, C, Veys, E M, Knecht, K, Van Hummelen, P, Remaut, E, Steidler, L, De Vos, M, Rottiers, P

    Published in Annals of the rheumatic diseases (01-10-2006)
    “…Background: Intestinal inflammation is a common feature of spondyloarthropathy (SpA) and Crohn’s disease. Inflammation is manifested clinically in Crohn’s…”
    Get full text
    Journal Article
  8. 8

    Overexpression of α1-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis by Hochepied, T, Wullaert, A, Berger, F G, Baumann, H, Brouckaert, P, Steidler, L, Libert, C

    Published in Gut (01-09-2002)
    “…Background: α1-Acid glycoprotein (α1-AGP) is an acute phase protein in most mammalian species whose concentration rises 2–5-fold during an acute phase…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis by STEIDLER, L, WELLS, J. M, RAYEMAEKERS, A, VANDEKERCKHOVE, J, FIERS, W, REMAUT, E

    Published in Applied and Environmental Microbiology (01-04-1995)
    “…Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  11. 11

    Lactococcus lactis, a tool for the delivery of therapeutic proteins treatment of IBD by Steidler, L

    Published in TheScientificWorld (11-05-2001)
    “…Inflammatory bowel disease (IBD) is a group of chronic intestinal inflammatory diseases that consists of ulcerative colitis (UC), an inflammation of the large…”
    Get full text
    Journal Article
  12. 12

    CD34+ megakaryocytes (≥30%) are associated with megaloblastic anaemia and non-acute myeloid neoplasia by Insuasti-Beltran, Giovanni, Steidler, Nichole L, Kang, Huining, Reichard, Kaaren K

    Published in Histopathology (01-10-2012)
    “…Insuasti‐Beltran G, Steidler N L, Kang H & Reichard K K 
(2012) Histopathology 61, 694–701 CD34+ megakaryocytes (≥30%) are associated with megaloblastic…”
    Get full text
    Journal Article
  13. 13

    Genetically engineered probiotics by Steidler, Lothar

    “…Probiotic micro-organisms have been used for many years. Originating as food supplements, they are now most often administered orally and offer an attractive…”
    Get full text
    Journal Article
  14. 14

    Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 by Steidler, Lothar, Neirynck, Sabine, Goddeeris, Bruno, Remaut, Erik, Remon, Jean Paul, Snoeck, Veerle, Vermeire, An, Huyghebaert, Nathalie, Cox, Eric

    Published in Nature biotechnology (01-07-2003)
    “…Genetically modified Lactococcus lactis secreting interleukin 10 provides a therapeutic approach for inflammatory bowel disease. However, the release of such…”
    Get full text
    Journal Article
  15. 15

    Pap pili as a vector system for surface exposition of an immunoglobulin G-binding domain of protein A of Staphylococcus aureus in Escherichia coli by STEIDLER, L, REMAUT, E, FIERS, W

    Published in Journal of Bacteriology (01-12-1993)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice by Vandenbroucke, Klaas, Hans, Wolfgang, Van Huysse, Jacques, Neirynck, Sabine, Demetter, Pieter, Remaut, Erik, Rottiers, Pieter, Steidler, Lothar

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-2004)
    “…Effective therapeutics for treating acute colitis, caused by disruption of the intestinal epithelial barrier, are scarce. Trefoil factors (TFF) are…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Production of Soluble and Active Recombinant Murine Interleukin-2 in Escherichia coli: High Level Expression, Kil-Induced Release, and Purification by Robbens, J., Raeymaekers, A., Steidler, L., Fiers, W., Remaut, E.

    Published in Protein expression and purification (01-08-1995)
    “…We describe the production of soluble murine interleukin-2 (mIL2) and its purification following regulated release in the growth medium of Escherichia coli…”
    Get full text
    Journal Article
  19. 19

    The expression of the Photinus pyralis luciferase gene in Staphylococcus aureus Cowan I allows the development of a live amplifiable tool for immunodetection by Steidler, L, Yu, W, Fiers, W, Remaut, E

    Published in Applied and Environmental Microbiology (01-07-1996)
    “…Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  20. 20

    Screening and construction of probiotic strains with enhanced protective properties against intestinal disorders by Mercenier, A., Hols, P., Roussel, Y., Perez-Martinez, G., Buesa, J., Wilks, M., Pozzi, G., Remaut, E., Morelli, L., Grangette, C., Monedero, V., Palumbo, E., Foligne, B., Steidler, L., Nutten, S.

    Published in Microbial ecology in health and disease (01-09-2004)
    “…Within the scope of the DEPROHEALTH project, a range of wild-type strains of Lactobacillus were analysed for their ability to interact with the host immune…”
    Get full text
    Journal Article